The share price of Vection Technologies Ltd [ASX:VR1] is up again today after announcing a move into healthcare. The VR1 share price is up 22%, trading at 8.3 cents. You can see the VR1 share price lighting up the charts after a long period of sideways trading…
Biotech Stocks: Investing in Cutting-Edge Healthcare Innovations
Immutep Share Price Pops 23% as Two Clinical Trials Show Promise
For many companies, making headway in a clinical trial is cause for celebration. But today, Immutep Ltd [ASX:IMM] has done it twice! That optimism has seen the IMM share price climb 23.26% higher at time of writing. A tidy return for a company…
Hydrix Shares Jump 37% Higher — Is the Medtech Boom on the Horizon?
My co-worker and fellow editor Lachlan recently covered this wonderful world of medtech. Shareholders of Hydrix Ltd [ASX:HYD] can tell you all about that. Because the company’s 22.64% share price gain today is just the latest win in a recent revival of this long-forgotten stock…
Recce Pharmaceuticals Share Price Up on New Trials (ASX:RCE)
The Sydney-based biotechnology company recently announced a phase 1 trial aimed at new classes of synthetic anti-infectives. At the time of writing the Recce Pharmaceuticals Ltd [ASX:RCE] share price is up 4.40%, to trade at $1.66, on the back of this positive announcement…
AnteoTech Share Price Climbs 15% Higher on COVID-19 Test News
The good news keeps on coming for stocks working on COVID-19 treatments. The latest company to confirm some good news is AnteoTech Ltd [ASX:ADO]. A small-cap biotech firm that has been working on a product that tests for COVID-19 symptoms…
Biotron Share Price Shoots 26% Higher on Preliminary COVID-19 Results
The hunt for a COVID-19 vaccine is ramping up. We learnt yesterday that the government has spent $1.7 billion on potential treatments. Hedging their bets on some $84 million worth of doses that will be ready for free rollouts by 2021…
